4X Recovery Blend Research Guide — Methionine + Choline + L-Carnitine + Dexpanthenol Lipotropic Combination Research (2026)
- The 4X Recovery Blend (YPB.268) is a four-component lipotropic research combination: Methionine (15mg) + Choline Chloride (50mg) + L-Carnitine (50mg) + Dexpanthenol (5mg). Unlike the KLOW Blend, this is not a peptide blend — it is a lipotropic amino acid / nutrient combination of compounds involved in hepatic lipid metabolism, one-carbon methylation, mitochondrial fatty acid oxidation, and coenzyme A (CoA) biosynthesis. Research Use Only (RUO).
- Classification note: Methionine is an essential amino acid (sulfur-containing); choline chloride is an essential nutrient (quaternary ammonium salt); L-carnitine is a carnitine amino acid derivative; dexpanthenol is the alcohol analogue of pantothenic acid (provitamin B5). None of these components is a peptide. This blend belongs to the lipotropic nutrient research category — compounds that promote hepatic fat processing and methylation pathway research.
- Combined research rationale: the four components address distinct but interconnected steps of hepatic lipid and one-carbon metabolism. Methionine is the methyl group donor (via SAM; S-adenosylmethionine) that drives methylation reactions and participates in phosphatidylcholine synthesis. Choline is required for VLDL assembly and hepatic triglyceride export. L-carnitine is required for the carnitine shuttle (CPT1/CPT2) transporting long-chain fatty acids into mitochondria for β-oxidation. Dexpanthenol is a provitamin B5 that is converted to pantothenic acid and then to coenzyme A (CoA), the obligate cofactor for fatty acid activation (acyl-CoA formation) and for acetyl-CoA in the TCA cycle. Together they provide a complete lipotropic research tool covering methyl donor (Methionine), hepatic export (Choline), mitochondrial transport (Carnitine), and CoA biosynthesis (Dexpanthenol). Updated April 2026.
- Research applications: hepatic steatosis models, lipid metabolism research, methylation pathway studies, mitochondrial fatty acid oxidation research, lipotropic injection protocol research design. Download the full catalog for all blend pricing. Research Use Only (RUO).
What Is the 4X Recovery Blend and What Does “Lipotropic” Mean?
Methylation + Fat Oxidation Pathways
Not a Peptide Blend
The term “lipotropic” refers to compounds that promote the metabolism and mobilization of lipids in the liver, reducing hepatic fat accumulation by facilitating the export or oxidation of fatty acids rather than their storage as triglycerides. Updated April 2026. The 4X Recovery Blend provides a research tool for studying four complementary lipotropic mechanisms simultaneously: methyl donor availability (Methionine), hepatic VLDL assembly and triglyceride export (Choline), mitochondrial long-chain fatty acid entry (L-Carnitine), and CoA availability for fatty acid activation and energy metabolism (Dexpanthenol).
This is a metabolic research compound blend, not a peptide blend. Researchers studying hepatic steatosis, non-alcoholic fatty liver disease (NAFLD) biology, methylation pathway dysfunction, or mitochondrial fatty acid oxidation will find the 4X Recovery Blend relevant as a multi-pathway lipotropic research tool. It is also relevant to researchers studying the biochemical basis of lipotropic injection formulations that have been used in metabolic compound.
Key Characteristics
| Parameter | Value |
|---|---|
| YPB SKU | YPB.268 |
| Classification | Lipotropic nutrient research combination (amino acid + essential nutrient + amino acid derivative + provitamin) |
| Composition | Methionine 15mg + Choline Chloride 50mg + L-Carnitine 50mg + Dexpanthenol 5mg (co-lyophilized in single vial) |
| Methionine (15mg) | Essential sulfur-containing amino acid; SAM (S-adenosylmethionine) precursor; universal methyl donor for methylation reactions; phosphatidylcholine synthesis via PEMT pathway |
| Choline Chloride (50mg) | Essential quaternary ammonium nutrient; phosphatidylcholine component; required for VLDL assembly and hepatic triglyceride export; acetylcholine precursor; one-carbon metabolism |
| L-Carnitine (50mg) | Amino acid derivative (synthesized from lysine and methionine); carnitine shuttle (CPT1/CPT2) for long-chain fatty acid transport into mitochondrial matrix for β-oxidation |
| Dexpanthenol (5mg) | Alcohol analogue of pantothenic acid (provitamin B5); converted to pantothenic acid → coenzyme A (CoA); essential cofactor for fatty acid activation (acyl-CoA), acetyl-CoA (TCA cycle), malonyl-CoA |
| Primary Research Applications | Hepatic steatosis models; methylation pathway research; mitochondrial FAO research; NAFLD biology; lipotropic combination research |
| FDA Status | Components individually are GRAS (generally recognized as safe) as food/supplement components; blend is a research preparation. Research Use Only (RUO). |
| WADA Status | Not listed on WADA Prohibited List 2025. L-carnitine is not prohibited (endogenous). |
| Storage | Lyophilized: −20°C. Reconstituted in sterile bacteriostatic water; 2–8°C, use within 14 days. |
The Four Lipotropic Pathways
Methionine: The Methyl Group Donor
Methionine is the starting point of the one-carbon (methyl donor) metabolic cycle. After absorption, methionine reacts with ATP to form SAM (S-adenosylmethionine) — the universal methyl donor for over 100 methylation reactions in the cell, including DNA methylation (epigenetic regulation), histone methylation, phosphatidylcholine synthesis via the phosphatidylethanolamine N-methyltransferase (PEMT) pathway, and creatine synthesis. SAM donates its methyl group → becomes SAH (S-adenosylhomocysteine) → homocysteine (which requires B12/folate to remethylate back to methionine or be transsulfurated to cysteine and then glutathione). In hepatic steatosis research, methionine deficiency models (methionine-choline deficient; MCD diet) are among the most commonly used experimental models for inducing hepatic fat accumulation and NASH-like pathology in rodents.
Choline: Hepatic VLDL Assembly and Phospholipid Synthesis
Choline is required for phosphatidylcholine (PC) synthesis — the primary structural phospholipid of all mammalian cell membranes and the essential component of VLDL (very low-density lipoprotein) particles that export triglycerides from the liver to peripheral tissues. Without adequate choline: (1) PC synthesis is impaired → VLDL assembly fails → hepatic triglycerides accumulate → hepatic steatosis; (2) PC is also required as a component of lipoprotein particles. Choline also participates in one-carbon metabolism (choline → betaine → methyl donor via BHMT; betaine-homocysteine methyltransferase) and is the precursor for acetylcholine in neuronal tissue. In the PEMT pathway, phosphatidylethanolamine is methylated three times by SAM (from methionine) to form phosphatidylcholine — creating a direct biochemical connection between the methionine and choline components of the 4X blend.
L-Carnitine: The Mitochondrial Fatty Acid Shuttle
Long-chain fatty acids (>C12) cannot cross the inner mitochondrial membrane without esterification to carnitine. The carnitine shuttle works as follows: fatty acid + CoA (acyl-CoA synthetase) → acyl-CoA → CPT1 (carnitine palmitoyltransferase 1, on outer mitochondrial membrane) transfers the acyl group to carnitine → acylcarnitine crosses inner mitochondrial membrane → CPT2 (on inner mitochondrial membrane matrix face) transfers acyl group back to CoA → acyl-CoA enters β-oxidation. Without carnitine, long-chain fatty acid β-oxidation in the mitochondrial matrix is impaired, forcing lipids toward cytoplasmic esterification and storage. L-carnitine supplementation in research models is used to study this CPT1/2-dependent fatty acid transport in the context of fatty acid oxidation efficiency.
Dexpanthenol: CoA Precursor
Dexpanthenol (D-panthenol) is the alcohol form of pantothenic acid (vitamin B5) and is rapidly oxidized to pantothenic acid in vivo. Pantothenic acid is the precursor to coenzyme A (CoA) through a five-step biosynthesis pathway. CoA is the universal acyl group carrier required for: fatty acid activation (acyl-CoA formation before β-oxidation or lipid synthesis); acetyl-CoA entry into the TCA cycle; malonyl-CoA synthesis for fatty acid elongation; and cholesterol synthesis. Without adequate CoA availability, fatty acid β-oxidation efficiency is compromised even when carnitine transport (L-carnitine) and methyl donor function (methionine/choline) are intact. Dexpanthenol is used as a CoA precursor in research models studying the relationship between B5 status, CoA availability, and lipid metabolism efficiency.
Research Applications
Hepatic Steatosis and NAFLD Models
The 4X Recovery Blend provides all four components depleted or dysfunctional in hepatic fat accumulation models: methionine-choline deficient (MCD) diet is the gold-standard experimental NASH model; carnitine deficiency impairs fatty acid oxidation; CoA availability limits β-oxidation efficiency. The blend provides a complete lipotropic rescue toolkit for studying whether restoring all four components simultaneously reverses MCD-induced steatosis more effectively than restoring individual components.
Methylation Pathway Research
The methionine + choline combination specifically covers both methyl donor routes: methionine → SAM (direct methylation) and choline → betaine → remethylation of homocysteine (via BHMT). This dual methyl donor coverage makes the 4X blend relevant for studying one-carbon metabolism insufficiency, elevated homocysteine (hyperhomocysteinemia), and epigenetic methylation dysregulation in metabolic disease models.
Mitochondrial Fatty Acid Oxidation Research
The L-carnitine + dexpanthenol combination specifically supports mitochondrial β-oxidation: carnitine provides the transport vehicle (CPT1/CPT2 shuttle); CoA (from dexpanthenol) provides the activation and processing cofactor. Researchers studying mitochondrial dysfunction in obesity, type 2 diabetes, or aging benefit from the combined carnitine/CoA tool that the 4X blend provides.
4X Recovery Blend vs. 8X Recovery Blend
| Parameter | 4X Recovery Blend (YPB.268) | 8X Recovery Blend (YPB.267) |
|---|---|---|
| Components | Methionine (15mg) + Choline Chloride (50mg) + L-Carnitine (50mg) + Dexpanthenol (5mg) | L-Carnitine (20mg) + L-Arginine (20mg) + Methionine (25mg) + Inositol (50mg) + Choline (50mg) + Vitamin B6 (25mg) + Vitamin B5 (5mg) + Vitamin B12 (1mg) |
| Primary Research Focus | Core lipotropic 4-pathway: methyl donor, hepatic export, mitochondrial transport, CoA biosynthesis | Expanded 8-pathway: adds inositol (insulin signaling), arginine (NO/urea), B6 (transamination/homocysteine), B12 (methylation cycle completion) |
| Unique to 4X | Dexpanthenol (provitamin B5/CoA precursor; not in 8X) | L-Arginine, Inositol, B6, B12 (not in 4X) |
| Best for | Focused lipotropic mechanism studies; MCD diet rescue; CPT1/carnitine pathway studies; CoA dependency research | Broader metabolic panel research; methylation cycle completeness (B12/B6 for homocysteine remethylation); insulin signaling + lipotropic combined |
Market Demand and Catalog Positioning
| Demand Indicator | 4X Recovery Blend Data Point |
|---|---|
| Research context | Hepatic steatosis/NAFLD; lipid metabolism; methylation; mitochondrial FAO; lipotropic injection protocol research |
| Catalog uniqueness | Only lipotropic nutrient blend in YPB catalog; non-peptide metabolic research product expanding catalog breadth |
| Progression | 4X (focused lipotropic) → 8X (expanded metabolic panel) provides natural catalog upgrade path |
| Buyer audience | Metabolic disease researchers; hepatology; lipid metabolism; integrative and functional compound research |
| Keyword difficulty range | Low (KD <5); high recognition due to lipotropic injection familiarity in integrative compound community |
Wholesale Pricing & White-Label Information
| SKU | Product | Premier ($497/mo) | Core ($297/mo) | MSRP |
|---|---|---|---|---|
| YPB.268 | 4X Recovery Blend (Methionine 15mg + Choline Cl 50mg + L-Carnitine 50mg + Dexpanthenol 5mg) | TBC Premier | TBC Core | TBC |
Contact the YPB team for confirmed Premier and Core pricing. Use the YPB Profit Calculator to model projected revenue. White-label brands offering both 4X and 8X Recovery Blends cover focused (4-component) and comprehensive (8-component) lipotropic research, addressing both experimental simplicity and metabolic panel completeness from a single metabolic research buyer audience. Download the full catalog for all metabolic blend pricing.
Methodology & Data Sources
Scientific literature: Well-established biochemical literature on methionine/SAM methylation, choline/phosphatidylcholine/VLDL, carnitine/CPT1-CPT2 shuttle, and pantothenic acid/CoA biochemistry. PubMed searched for “methionine choline deficient NASH,” “carnitine CPT1 fatty acid oxidation,” and “pantothenic acid CoA lipid metabolism.” Search conducted through April 2026. This article is for educational purposes only.
References
- Stipanuk, M. H. (2004). Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr, 24, 539–577. (Methionine/SAM methylation cycle.)
- Zeisel, S. H., & da Costa, K. A. (2009). Choline: an essential nutrient for public health. Nutr Rev, 67(11), 615–623. (Choline/phosphatidylcholine/VLDL assembly.)
- Longo, N., Amat di San Filippo, C., & Pasquali, M. (2006). Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet, 142C(2), 77–85. (CPT1/CPT2 carnitine shuttle.)
- Leonardi, R., Zhang, Y. M., Rock, C. O., & Jackowski, S. (2005). Coenzyme A: back in action. Prog Lipid Res, 44(2–3), 125–153. (Pantothenic acid/CoA biosynthesis and function.)
- Anstee, Q. M., & Goldin, R. D. (2006). Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol, 87(1), 1–16. (MCD diet hepatic steatosis model context.)
Frequently Asked Questions
The 4X Recovery Blend (YPB.268) is a four-component lipotropic research combination: Methionine (15mg; essential amino acid; SAM methyl donor; phosphatidylcholine synthesis via PEMT) + Choline Chloride (50mg; essential nutrient; phosphatidylcholine/VLDL assembly; betaine methyl donor; acetylcholine precursor) + L-Carnitine (50mg; amino acid derivative; CPT1/CPT2 mitochondrial long-chain fatty acid shuttle) + Dexpanthenol (5mg; provitamin B5; CoA precursor; fatty acid activation, acetyl-CoA, TCA cycle cofactor). Classification: lipotropic nutrient blend — not a peptide blend. All four components support hepatic lipid metabolism and fatty acid oxidation through complementary pathways: methyl donor (Methionine), hepatic export (Choline), mitochondrial transport (L-Carnitine), and CoA biosynthesis (Dexpanthenol). Research Use Only (RUO). Updated April 2026.
The “recovery” designation in the product name reflects the blend’s role in supporting metabolic recovery and lipid homeostasis biology — restoring lipotropic cofactors that support efficient hepatic fat processing and mitochondrial function. In the research context, lipotropic blends are studied for their role in recovering hepatic function in steatosis models (restoring efficient VLDL export via choline, re-establishing fatty acid oxidation via carnitine, replenishing CoA via dexpanthenol) and supporting methylation pathway integrity (methionine SAM). The term “recovery” is a catalog positioning descriptor, not a mechanistic claim. All four components are research-grade nutrients/amino acid derivatives studied in metabolic biology; none are approved for any therapeutic recovery indication. Research Use Only.
Dexpanthenol (D-panthenol; R-panthenol) is the alcohol analogue of D-pantothenic acid (vitamin B5): the carboxylic acid group of pantothenic acid is replaced by an alcohol group. After absorption or entry into cells, dexpanthenol is oxidized by pantothenol dehydrogenase to pantothenic acid, and then pantothenic acid proceeds through a five-step enzymatic pathway to become coenzyme A (CoA). Dexpanthenol is used as a B5 precursor in research formulations because it is more stable than pantothenic acid in certain buffer conditions (the alcohol form is less reactive than the acid form) and is efficiently converted to the active pantothenic acid form intracellularly. The 5mg dose of dexpanthenol in the 4X blend provides a modest CoA precursor load appropriate for research models studying the relationship between B5 availability and lipid metabolism efficiency; it is not intended as a pharmacological dose but as a research-level supplementation of the CoA biosynthesis pathway.
The 4X Recovery Blend (YPB.268) contains four core lipotropic components: Methionine + Choline Chloride + L-Carnitine + Dexpanthenol. The 8X Recovery Blend (YPB.267) expands to eight components: L-Carnitine + L-Arginine + Methionine + Inositol + Choline + Vitamin B6 (Pyridoxine) + Vitamin B5 (Pantothenic Acid) + Vitamin B12 (Cyanocobalamin). The 8X adds four components not present in 4X: (1) L-Arginine: nitric oxide synthesis precursor, urea cycle, protein synthesis; (2) Inositol: second messenger (IP3), insulin signaling, phospholipid synthesis (PI); (3) Vitamin B6: pyridoxal phosphate (PLP) cofactor for transaminases and cystathionine beta-synthase (homocysteine transsulfuration pathway); (4) Vitamin B12: methylcobalamin for methionine synthase (homocysteine remethylation) completing the methylation cycle. The 8X provides a more complete metabolic panel covering the full methylation cycle (B12 + methionine), arginine/NO pathway, and inositol signaling alongside the core lipotropic components. Choose 4X for focused lipotropic pathway research; choose 8X for comprehensive metabolic panel research or when the homocysteine/methylation cycle completeness is important to the study design.
Yes. YourPeptideBrand.com provides white-label dropship for the 4X Recovery Blend as YPB.268 (Research Use Only). White-label storefronts include pre-built RUO-compliant product pages with lipotropic mechanism descriptions, component composition table, and COA library links. This blend is positioned as a lipotropic nutrient research combination (not a peptide blend) and should be clearly labeled as such in catalog copy. Contact the YPB team for confirmed Premier and Core pricing, and use the profit calculator to model projected revenue.
Every 4X Recovery Blend batch includes a lot-specific COA confirming each component by identity (MS or HPLC for each of the four components at their respective molecular weights: Methionine ~149 Da; Choline Chloride ~140 Da; L-Carnitine ~161 Da; Dexpanthenol ~205 Da), HPLC purity of the overall blend, endotoxin (<1 EU/mg), TAMC, and TYMC. All lots are traceable through the batch-specific COA library.
Position the 4X and 8X as a focused-to-comprehensive progression in lipotropic research: 4X covers the four core lipotropic mechanisms (methyl donor, VLDL export, mitochondrial transport, CoA biosynthesis) for targeted pathway studies; 8X expands to eight components adding the complete methylation cycle (B12 for methionine synthase, B6 for transsulfuration), arginine/NO pathway, and inositol/PI signaling. The 4X is the “precision lipotropic” tool; the 8X is the “comprehensive metabolic panel”. Both should be clearly labeled as lipotropic nutrient research blends (not peptide products) to maintain accurate catalog categorization. The two blends together serve different research design requirements from the same lipid metabolism and metabolic disease research buyer audience.
The 4X Recovery Blend is most appropriate for research models focused on hepatic lipid metabolism and fat oxidation: (1) Methionine-choline deficient (MCD) diet hepatic steatosis rescue models — the blend provides the two depleted nutrients (methionine and choline) plus the downstream carnitine and CoA support for complete lipotropic rescue; (2) In vitro hepatocyte steatosis models (e.g., palmitate-treated HepG2 cells) where lipotropic pathway support is tested; (3) Carnitine shuttle research — the carnitine + dexpanthenol/CoA combination specifically addresses the CPT1/CPT2 transport step and acyl-CoA activation; (4) One-carbon/methylation research — the methionine + choline dual methyl donor provision enables research on SAM-dependent methylation and BHMT-dependent remethylation simultaneously; (5) NAFLD/metabolic disease models where lipotropic support is a research variable. Models where the full methylation cycle completion (B12/B6), insulin signaling (inositol), or NO pathway (arginine) are also research variables should use the 8X blend instead.
Key Takeaways
Research Takeaways
- Lipotropic nutrient blend (not peptides): Methionine (amino acid/SAM donor) + Choline Chloride (essential nutrient/phosphatidylcholine) + L-Carnitine (amino acid derivative/CPT shuttle) + Dexpanthenol (provitamin B5/CoA precursor).
- Four complementary lipotropic pathways: Methyl donor (SAM) → hepatic PC/VLDL export (Choline) → mitochondrial long-chain FA transport (Carnitine) → acyl-CoA activation (Dexpanthenol/CoA).
- Metabolic interconnections: Carnitine is synthesized from methionine (methyl group); choline can be synthesized from methionine (PEMT pathway); CoA is required for the carnitine acyl-CoA step; all four are coupled in hepatic lipid metabolism.
- MCD diet rescue model: Most relevant experimental model for testing all four components simultaneously.
- 4X vs. 8X: 4X = focused lipotropic core; 8X = expanded metabolic panel with B12/B6/arginine/inositol.
Business Takeaways
- Non-peptide catalog expansion — adds lipotropic nutrient research segment alongside peptide catalog.
- 4X → 8X progression = natural upgrade path; focused lipotropic → comprehensive metabolic panel.
- Contact YPB for confirmed pricing on YPB.268.
Ready to add 4X Recovery Blend to your research catalog? Book a consultation with the YPB team.
[ypb_studies peptide=”4x-recovery-blend”]